MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.biopha.2024.116427

Медицинская библиотека · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024

HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, -10 and -11.

Su Yixi, Liu Jiaqi, Tian Yu, Dong Haiyan, Shi Mengchen, Zhang Jingdan, Li Weiqian, Huang Qiang, Xiang Nanlin, Wang Chen, Liu Jun, He Lingyuan, Hu Limei, Haberman Ann M, Liu Huanliang, Yang Xiangling

СтатьяПеревод пока не подготовлен

Аннотация

Uncertainty exists regarding the mechanisms by which hypoxia-inducible factors (HIFs) control CD8+T-cell migration into tumor microenvironments. Here, we found that HIF-1α knockdown or overexpression resulted in increased or decreased CXCL9, -10, and -11 expression in vitro, respectively. Gene Set Variation Analysis revealed that elevated HIF-1α levels correlated with a poor prognosis, severe pathological stage, and an absence of CD8+ T cells in the tumor microenvironment in colorectal cancer (CRC) patients. HIF-1α was inversely associated with pathways beneficial to anti-tumor immunotherapy and cytokine/chemokine function. In vivo, inhibiting HIF-1α or its upstream regulator BIRC2 significantly suppressed tumor growth and promoted CD8+ T-cell infiltration. CXCR3 neutralizing antibodies reversed these effects, implicating the involvement of CXCL9, -10, and -11/CXCR3 axis. The presence of HIF-1α weakened the upregulation of CXCL9, -10, and -11 by bleomycin and doxorubicin. Combining HIF-1α inhibition with bleomycin promoted CD8+ T-cell infiltration and tumor suppression in vivo. Moreover, doxorubicin could upregulate CXCL9, -10 and -11 by suppressing HIF-1α. Our findings highlight the potential of HIF-1α inhibition to improve CRC microenvironments and increase chemotherapy sensitivity.

Для цитирования: Su Yixi, Liu Jiaqi, Tian Yu, Dong Haiyan, Shi Mengchen, Zhang Jingdan, Li Weiqian, Huang Qiang, Xiang Nanlin, Wang Chen, Liu Jun, He Lingyuan, Hu Limei, Haberman Ann M, Liu Huanliang, Yang Xiangling. HIF-1α Mediates Immunosuppression and Chemoresistance in Colorectal Cancer by Inhibiting CXCL9, -10 and -11.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2024. DOI: 10.1016/j.biopha.2024.116427.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.